Federated Hermes, Inc. Care Dx, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 35,914 shares of CDNA stock, worth $769,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,914

Previous 37,003 2.94%

Holding current value

$769,277

Previous $574,000 95.3%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$14.41 - $33.99 $15,692 - $37,015	-1,089 Reduced 2.94%	35,914 $1.12 Million
Q2 2024 Aug 08, 2024	BUY	$7.56 - $16.15 $19,172 - $40,956	2,536 Added 7.36%	37,003 $574,000
Q1 2024 May 14, 2024	BUY	$7.96 - $12.37 $48,914 - $76,013	6,145 Added 21.7%	34,467 $365,000
Q4 2023 Jan 31, 2024	SELL	$4.9 - $12.86 $23,544 - $61,792	-4,805 Reduced 14.5%	28,322 $339,000
Q3 2023 Nov 13, 2023	SELL	$7.0 - $11.26 $195,986 - $315,257	-27,998 Reduced 45.8%	33,127 $231,000
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $756,274 - $940,125	-99,379 Reduced 61.92%	61,125 $519,000
Q1 2023 May 08, 2023	BUY	$8.83 - $17.61 $680,881 - $1.36 Million	77,110 Added 92.46%	160,504 $1.47 Million
Q4 2022 Feb 13, 2023	SELL	$10.88 - $20.05 $1.73 Million - $3.18 Million	-158,781 Reduced 65.56%	83,394 $951,000
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $3.23 Million - $5.31 Million	201,183 Added 490.79%	242,175 $4.12 Million
Q2 2022 Aug 15, 2022	BUY	$20.49 - $39.72 $839,926 - $1.63 Million	40,992 New	40,992 $881,000
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $1.22 Million - $1.9 Million	-20,675 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $1.45 Million - $2.19 Million	-23,006 Reduced 52.67%	20,675 $1.89 Million
Q1 2021 May 13, 2021	SELL	$57.62 - $95.6 $7.51 Million - $12.5 Million	-130,312 Reduced 74.89%	43,681 $2.97 Million
Q4 2020 Feb 12, 2021	BUY	$41.43 - $77.09 $7.21 Million - $13.4 Million	173,978 Added 1159853.38%	173,993 $12.6 Million
Q3 2020 Nov 12, 2020	BUY	$30.88 - $37.94 $185 - $227	6 Added 66.67%	15 $1,000
Q2 2020 Aug 13, 2020	BUY	$18.95 - $35.43 $170 - $318	9 New	9 $1,000
Q3 2019 Nov 14, 2019	SELL	$20.03 - $40.08 $6,329 - $12,665	-316 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$25.78 - $39.77 $6.19 Million - $9.55 Million	-240,058 Reduced 99.87%	316 $11,000
Q1 2019 May 10, 2019	BUY	$22.09 - $39.21 $1.31 Million - $2.32 Million	59,119 Added 32.62%	240,374 $7.58 Million
Q4 2018 Feb 13, 2019	BUY	$19.89 - $30.02 $3.36 Million - $5.07 Million	168,898 Added 1366.82%	181,255 $4.56 Million
Q3 2018 Nov 13, 2018	BUY	$12.1 - $28.85 $146,155 - $348,479	12,079 Added 4344.96%	12,357 $356,000
Q2 2018 Aug 10, 2018	BUY	$7.93 - $15.79 $2,204 - $4,389	278 New	278 $3,000

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Care Dx, Inc. Transaction History